Page last updated: 2024-09-05

atropine and No-Reflow Phenomenon

atropine has been researched along with No-Reflow Phenomenon in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fu, Q; Huang, YJ; Jiang, SZ; Lu, W; Wang, HB; Wang, LG; Wang, YJ; Wu, Q	1

Other Studies

1 other study(ies) available for atropine and No-Reflow Phenomenon

Article	Year
Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. Cell biochemistry and biophysics, 2013, Volume: 67, Issue:3 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Atropine; Bradycardia; Coronary Angiography; Female; Humans; Hypotension; Incidence; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Retrospective Studies; Stents; Treatment Outcome; Vasodilator Agents; Verapamil	2013

Article

Year

Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.

Cell biochemistry and biophysics, 2013, Volume: 67, Issue:3

Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Atropine; Bradycardia; Coronary Angiography; Female; Humans; Hypotension; Incidence; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Retrospective Studies; Stents; Treatment Outcome; Vasodilator Agents; Verapamil

2013